Barts Health NHS Trust

What Barts Health NHS Trust does

Barts Health NHS Trust is the largest NHS trust in the UK, formed in April 2012 through the merger of five East London NHS trusts: St Bartholomew's Hospital, The Royal London Hospital, Newham University Hospital, Whipps Cross University Hospital, and Mile End Hospital. The trust operates as a statutory public-sector organisation, accountable to NHS England and the Department of Health and Social Care, and serves a catchment population of approximately 2.6 million people across East London. It runs the UK's busiest major trauma centre at The Royal London Hospital, the Barts Heart Centre (one of Europe's largest cardiac centres) and the Barts Cancer Centre, alongside 24/7 A&E, maternity (delivering around 40 babies daily), dental, and community services. Leadership comprises Shane DeGaris as Chief Executive and Professor Ian Jacobs as Chair.

The trust's core technology layer combines NHS national digital infrastructure with proprietary extensions: NHS App and Patients Know Best integration for patient record access, DrDoctor for digital outpatient appointment letters, a Barts Health Data Platform providing large-scale research data access, an AI heart failure screening tool invented by an in-house clinician, and Virtual Ward/COPD remote monitoring. Research infrastructure is a defining asset: the NIHR Barts Biomedical Research Centre, NIHR Barts Clinical Research Facility, and the NIHR North East London Commercial Research Delivery Centre, all operated jointly with Queen Mary University of London. The trust's research arm co-led the RECOVERY trial (identifying dexamethasone as a COVID-19 treatment) and the JAVELIN Bladder 100 trial (31% mortality reduction in bladder cancer via avelumab).

Barts Health is funded primarily through NHS government allocation via Payment by Results and block contracts, with marginal diversification into private patient services (Barts Health Private Care), chargeable overseas visitor services, Barts Charity grants, and targeted external grants (e.g., £198,000 from the British Heart Foundation for the HealthTab cholesterol pilot). Reported turnover was £1.4 billion in 2017 with approximately 16,000 staff; current headcount is approximately 24,000 staff and volunteers. The Barts Life Sciences Cluster represents a £800 million-plus public-private initiative in Whitechapel aimed at building a life sciences and AI/digital health innovation cluster anchored to the trust's clinical and research base.

Name

Barts Health NHS Trust

Legal name

Barts Health NHS Trust

Website

https://bartshealth.nhs.uk

Company type

Public

Founded year

2012

Operating status

Operating

Headcount range

5,001–10,000 employees

Short description

Barts Health NHS Trust is the UK's largest NHS trust, operating five hospitals across East London to serve 2.6 million people with acute, specialist, and research-driven healthcare. Publicly funded through NHS allocation, it is expanding into life sciences, AI clinical tools, and community-based preventive care.

Ownership category

akta.pro rank

Product category

Hospital Healthcare Services

NAICS

General Medical and Surgical Hospitals (6221), General Medical and Surgical Hospitals (622110), Hospitals (622)

SIC

Services-General Medical & Surgical Hospitals, Nec (8062), Services-Hospitals (8060)

akta.pro primary industry

Community & Regional General Hospitals (HLAFAAAB)

akta.pro secondary industries

Hospital-Owned Physician Networks & Medical Groups (HLAFAAAL), Children’s Hospitals (Acute Care) (HLAFAAAI)

Keywords

• NHS hospital services
• Specialist cardiac care
• Oncology treatment services
• Maternity and emergency care
• Clinical research infrastructure

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices6 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. NHS Government Funding: Barts Health NHS Trust is publicly funded through NHS government allocation. The trust receives funding based on NHS Payment by Results (PbR) system and block contracts for healthcare services provided to the population of east London.
2. Private Patient Services: The trust operates Barts Health Private Care (bartshealthprivatecare.com) providing private healthcare services to self-paying and insured patients.
3. Overseas Patients: Chargeable services to overseas visitors not covered by NHS entitlements.
4. Charitable Donations: Funding through Barts Charity for research facilities, equipment, and patient care improvements.

Go-to-market motion1 record

Distribution channels6 records

Marketing channels7 records

Core offering

Barts Health NHS Trust operates five NHS hospitals across East London delivering comprehensive public healthcare services including accident and emergency care, specialist cardiac services (Barts Heart Centre), oncology services (Barts Cancer Centre), and maternity services that deliver approximately 40 babies daily. The trust also runs clinical research infrastructure through NIHR-funded centres, a life sciences cluster initiative with over £800 million planned investment, private patient services through Barts Health Private Care, and digital patient engagement via NHS App integration with Patients Know Best and DrDoctor.

Product overview

Barts Health NHS Trust operates as a unified NHS hospital network of five hospitals across East London: The Royal London Hospital (major trauma centre), St Bartholomew's Hospital (specialist cardiac and cancer care), Newham Hospital, Whipps Cross Hospital, and Mile End Hospital. The trust delivers comprehensive acute care including emergency services, maternity care (delivering 50% more babies than any other London trust), specialized cardiac and cancer services, and dental care. The organization has expanded into digital health with the Barts Health Data Platform for research, NHS App integration for patient access, and pilot programs including HealthTab for community pharmacy cholesterol management. Research infrastructure includes the NIHR Barts Biomedical Research Centre, Clinical Research Facility, and the Commercial Research Delivery Centre, all partnered with Queen Mary University of London. Barts Life Sciences represents an £800 million life sciences cluster initiative for MedTech, AI, and digital health innovation.

Differentiator

Problem solved

Functional benefit

Brands

• Barts Heart Centre: Specialist cardiac care centre at St Bartholomew's Hospital, one of Europe's biggest cardiac centres.
• Barts Cancer Centre
• Barts Life Sciences
• Vital Arts
• NIHR Barts Biomedical Research Centre
• NIHR Barts Clinical Research Facility
• Academic Centre for Healthy Ageing (ACHA)

Products and services

• Barts Heart Centre Specialist cardiac centre at St Bartholomew's Hospital providing comprehensive heart care including cardiac surgery and interventional procedures for patients across East London and beyond.
• Barts Cancer Centre Specialist oncology centre providing cancer diagnosis, treatment, and clinical trial services, integrated with the Barts Cancer Institute research partnership with Queen Mary University of London.
• Maternity Services Comprehensive maternity care including antenatal, delivery, and postnatal care delivered across all five Barts Health hospitals, with approximately 40 babies born daily — 50% more than any other part of London.
• Accident & Emergency Services 24/7 A&E departments at multiple hospital sites including The Royal London Hospital which serves as a major trauma centre for North East London.
• Barts Health Private Care Private healthcare service unit providing specialist care to self-paying and insured patients outside of standard NHS provision, operated at bartshealthprivatecare.com.
• Overseas Patients Service Chargeable healthcare services for overseas visitors who are not covered by NHS entitlement, delivered through the trust's standard hospital services.
• Barts Health Data Platform Secure data platform providing large-scale data access to support research, innovation, and improved patient outcomes for academics, clinicians, and pharmaceutical researchers.
• NIHR Barts Biomedical Research Centre NIHR-funded biomedical research centre focusing on cardiovascular disease and precision medicine research, operated jointly with Queen Mary University of London.
• NIHR Barts Clinical Research Facility Clinical research facility at The Royal London Hospital supporting early phase clinical trials and research expansion, funded by NIHR and run in partnership with Queen Mary University of London.
• HealthTab Cholesterol Management Pilot Pilot programme deploying the HealthTab platform through community pharmacies across North East London to deliver inclisiran cholesterol-lowering injections and long-term lipid management, integrating with Barts Health hospital systems.
• Cholesterol Point of Care Testing Pilot Completed pilot programme delivering point-of-care cholesterol testing in community pharmacies across North East London, commissioned by Barts Health NHS Trust and serving 556 patients across seven locations.
• NHS App Patient Portal Integration Digital patient engagement platform integrating Patients Know Best health records and DrDoctor appointment letters into the NHS App, allowing patients to view test results, manage appointments, and access hospital records with support for 22 languages.
• Dental Hospital Services Specialist dental hospital service provided as part of Barts Health's A-Z of services for patients requiring dental treatment and oral health services.
• Vital Arts Creative Health Programme In-house creative health team delivering arts and creative programmes for patients across Barts Health hospitals, supporting wellbeing and the hospital environment.

Quantifiable outcome

• 43% reduction in low-birth-weight babies after 40 weeks through Newham Maternity SGA QI Project
• +6 more outcomes

Named customers4 records

Segments6 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability4 records

Feature5 records

Partnerships

Ten partnerships are on record, tiered flagship, core and minor.

• Barts Life Sciences Cluster PartnershipflagshipStrategic or Co-development Partner · 25 November 2025The Barts Life Sciences Cluster officially launched in Whitechapel, East London, with planned investment of over £800 million. The initiative involves partnership between Barts Health NHS Trust, private investors, academic institutions, and government support, aimed at transforming healthcare and fostering innovation in MedTech, AI, and digital health.
• Queen Mary BioEnterprises Innovation Centre (QMB)coreStrategic or Co-development Partner · 23 December 2024Strategic partnership to develop 40,000 square feet of incubator space at the flagship innovation centre in Whitechapel, London. Collaboration involves Barts Life Sciences, Barts Health NHS Trust, Queen Mary University of London, and UK Department of Health and Social Care. Aims to create a world-class life sciences cluster nurturing startup companies, generating high-quality jobs, and promoting education in life sciences and STEM sectors.
• Lateral (Development Partner)minorStrategic or Co-development Partner · 23 December 2024Development partner collaborating with H.I.G. Realty and Queen Mary BioEnterprises Innovation Centre on the Whitechapel Life Science Cluster project.
• UK Department of Health and Social CarecoreStrategic or Co-development Partner · 23 December 2024Government partner involved in establishing the Whitechapel Life Science Cluster, providing support for creating jobs, career pathways, and education in biopharmaceutical and STEM sectors.
• Queen Mary University of LondoncoreStrategic or Co-development PartnerLong-standing research partnership with Queen Mary University of London as part of Barts Life Sciences. Includes Faculty of Medicine and Dentistry, NIHR Barts Biomedical Research Centre, Barts Cancer Institute, and Genes & Health programme. Partnership drives improvements in treatments and healthcare services.
• National Institute for Health and Care Research (NIHR)coreStrategic or Co-development PartnerNIHR Barts Biomedical Research Centre and NIHR Barts Clinical Research Facility. Also NIHR North East London Commercial Research Delivery Centre (one of 35 CRDCs in UK) in partnership with Barking, Havering and Redbridge University NHS Trust and Homerton Healthcare NHS Foundation Trust.
• Genes & Health ProgrammeminorStrategic or Co-development PartnerResearch collaboration to increase research funding and recruitment to clinical trials from local, diverse populations to ensure research is representative and will benefit everyone.
• Macmillan Cancer SupportminorStrategic or Co-development PartnerPartnership providing specialist cancer information services to patients. Volunteers support Macmillan Centres and visit patients on wards ensuring information leaflets are available.
• North East London ICBcoreStrategic or Co-development PartnerIntegrated Care Board partnership for coordinating healthcare services across north east London, including urgent care centres and pharmacy referrals.
• The Nightingale Hospital (Temporary COVID-19 Facility)minorStrategic or Co-development PartnerTemporary hospital facility established during COVID-19 pandemic where Barts Health clinical research teams conducted research and enrolled patients into clinical trials including RECOVERY trial.

Scale indicators11 records

Recent moves8 records

Expansion highlights5 records

Broad incumbents

• Mass General Brigham: Large US academic medical system combining multiple specialty hospitals, a major research enterprise, and life sciences commercial activity. Useful international benchmark for Barts Health's ambition to integrate clinical care, research, and a life sciences cluster.
• Mount Sinai Health System: Urban US academic health system anchored in a diverse metropolitan catchment with strong specialty centres, research output, and life sciences commercial partnerships. Comparable to Barts Health in serving a diverse urban population and operating a research-driven multi-site model.

Direct peers

• University College London Hospitals NHS Foundation Trust: London teaching hospital trust co-located within UCL Partners (the same academic health science network as Barts Health), with comparable research intensity, specialist services, and digital health ambitions. Strong overlap in patient population and academic linkages.
• Newcastle upon Tyne Hospitals NHS Foundation Trust: Major UK teaching hospital trust with strong research output, NIHR infrastructure, and a regional referral role. Comparable to Barts Health on academic-clinical integration and specialty service depth.
• Imperial College Healthcare NHS Trust: Large London acute and teaching hospital trust with five hospitals, NIHR Biomedical Research Centre, and close ties to Imperial College London. Directly comparable to Barts Health on multi-site acute care, academic partnership, and research intensity.
• Royal Free London NHS Foundation Trust: Large London NHS trust operating multiple hospital sites with a strong research base (UCLPartners affiliate) and significant specialist services. Comparable to Barts Health in multi-site operations and academic-medical positioning.
• Guy's and St Thomas' NHS Foundation Trust: One of the largest NHS trusts in the UK, operating multiple hospital sites across central/south London with major teaching, research, and specialist service portfolios. Highly comparable to Barts Health in scale, academic affiliation, and specialist centre footprint.
• King's College Hospital NHS Foundation Trust: Major south London teaching trust with significant specialist services (cardiac, neurosciences, liver) and strong research base. Comparable to Barts Health as a tertiary referral centre serving a diverse metropolitan population.
• Cambridge University Hospitals NHS Foundation Trust: UK academic teaching hospital with major research output via the Cambridge Biomedical Research Centre and life sciences cluster (similar to Barts Life Sciences). Comparable on the research-commercial nexus and biomedical innovation strategy.
• Manchester University NHS Foundation Trust: Largest NHS trust in England by turnover outside London, formed via merger of multiple hospitals with major teaching, research, and specialist service portfolios. Directly comparable on multi-site integration, scale, and academic-medical-centre profile.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/nhsbartshealth
• YouTubeyoutube.com/channel/UCYl9AzsVwS_4Swt4VZ1dhuQ
• Facebookfacebook.com/bartshealth
• LinkedInlinkedin.com/company/barts-health-nhs-trust
• Instagraminstagram.com/nhsbartshealth

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles11 records

Subsidiaries9 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Barts Health NHS Trust